Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How does sharewise work?

1

Sign up for free

Get yourself a free user account

Show more
2

Look for a stock/index

Choose a specific stock or index

Show more
3

Discuss

Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard

Show more
4

Engage

Help us make sharewise better and help us in making it a success

Show more
sharewise ist auf Deutsch und Englisch verfügbar.
sharewise is available in German and English.

Top Buy/Sell (This Month)

Security Price Target price
Tesla Inc €268.15 €284.80
Oracle Corp. €197.18 €200.00
Micron Technology Inc. €106.54 €125.44
Security Price Target price
Texas Capital Bancshares €74.00 €69.59
First Hawaiian Inc €22.40 €20.96
Werner Enterprises Inc. ? €25.08

New Top predictions since last week

Many tell you which stocks to buy.

We measure how often they are right!

Portfolios of our members

Volatus Aerospace Inc. 1000%
Total
€261,456
Cash
€13,956
Performance (%)
161.456%

Pros and Cons of these stocks (New Predictions)

Nektar Therapeutics

WKN: A419UB / Name: Nektar Therapeutics / Stock / ? /

Pros
Cons
2
Probably not worthwhile Investment
1
Few uniques
1
Dependend from some customers or products
Wolfspeed Inc.

WKN: A3C4QG / Symbol: CREE / Name: Wolfspeed / Stock / Semiconductors & Semiconductor Equipment / Mid Cap /

Pros
Cons
1
Very high cyclical dependencies
1
Below average Marketposition
1
Little known brand
Try sharewise+ and get hundreds more matching stocks
Sign up for free!

Tops & Flops S&P 500

Security Price Change(%) (%)
Advance Auto Parts Inc. €50.98 5.900%
Discovery Communications C €22.42 5.110%
Lam Research Corp. €7,371.0 3.990%
Westrock Co €47.53 3.930%
Halliburton Co. €19.73 3.380%
Security Price Change(%) (%)
Paypal Holdings Inc €61.06 -5.620%
American Airlines Group Inc. €10.47 -5.310%
Gilead Sciences Inc €93.80 -4.310%
V.F. Corp. €10.56 -4.250%
United Continental Holdings €75.01 -4.020%

Courses

Key figures for stocks: https://unsplash.com/@markusspiske?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText
Key figures for stocks
Keeping an eye on the various key figures is important. We tell you what they mean.
sharewise advanced features:
sharewise advanced features
You learn how to find  the latest news and find great financial information about your stocks.
Also you get more information about our Pro and Cons feature, where we bring the wisdom of crowds to a new level.

For discussing with your friends and managing your investment clubs we will show you how to create your own stock debates.#

Predictions

buy
Deutsche Börse AG ADR

Start price
Target price
Perf. (%)
€26.80
22:30
-
11.07.26
-
10.07.25

buy
Equinix Inc.

Start price
Target price
Perf. (%)
€647.80
21:45
€813.68
11.07.26
0.00%
22:26

buy
Ameren Corp.

Start price
Target price
Perf. (%)
€82.50
21:15
€97.64
11.07.26
0.00%
22:26

buy
ConocoPhillips

Start price
Target price
Perf. (%)
€82.19
21:15
€98.50
11.07.26
-0.50%
22:26

Top News

News

Nestle Stock: Water Scandal Sparks French Probe
Nestle Stock: Water Scandal Sparks French Probe

The Swiss food giant Nestle is facing increased scrutiny after French authorities raided its headquarters near Paris in connection with allegations of illegal water treatment practices. The

Levi Strauss' Q2 Earnings Beat Estimates on Solid DTC Business: https://staticx-tuner.zacks.com/images/articles/main/82/2603.jpg
Levi Strauss' Q2 Earnings Beat Estimates on Solid DTC Business

Levi Strauss & Co. LEVI reported second-quarter fiscal 2025 results, wherein earnings per share (EPS) and revenues beat the Zacks Consensus Estimate. Both metrics improved year over year. The

FDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV Pill: https://staticx-tuner.zacks.com/images/articles/main/ef/472.jpg
FDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV Pill

Merck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its investigational, once-daily, oral, two-drug, single-tablet regimen of

Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?: https://staticx-tuner.zacks.com/images/default_article_images/default36.jpg
Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Cencora (COR), which belongs to the

Will CNX Resources (CNX) Beat Estimates Again in Its Next Earnings Report?: https://staticx-tuner.zacks.com/images/default_article_images/default35.jpg
Will CNX Resources (CNX) Beat Estimates Again in Its Next Earnings Report?

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? CNX Resources Corporation. (CNX), which

Will Cullen/Frost (CFR) Beat Estimates Again in Its Next Earnings Report?: https://staticx-tuner.zacks.com/images/default_article_images/default33.jpg
Will Cullen/Frost (CFR) Beat Estimates Again in Its Next Earnings Report?

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Cullen/Frost Bankers (CFR), which

Will CSW Industrials (CSW) Beat Estimates Again in Its Next Earnings Report?: https://staticx-tuner.zacks.com/images/default_article_images/default37.jpg
Will CSW Industrials (CSW) Beat Estimates Again in Its Next Earnings Report?

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider CSW

Why Chord Energy Corporation (CHRD) is Poised to Beat Earnings Estimates Again: https://staticx-tuner.zacks.com/images/default_article_images/default34.jpg
Why Chord Energy Corporation (CHRD) is Poised to Beat Earnings Estimates Again

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Chord Energy Corporation (CHRD), which

Will Certara (CERT) Beat Estimates Again in Its Next Earnings Report?: https://staticx-tuner.zacks.com/images/default_article_images/default40.jpg
Will Certara (CERT) Beat Estimates Again in Its Next Earnings Report?

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Certara, Inc. (CERT), which belongs to the

Contest

Compete in Catch the Monkey ...

... and win a prize!

Heibel Ticker

sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.

Kostenlos ausprobieren

Leeway

Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.

Kostenlos ausprobieren

sharewise

Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer sharewise+-Mitgliedschaft unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Jetzt kostenlos ausprobieren

sharewise

Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer sharewise+-Mitgliedschaft unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Jetzt kostenlos ausprobieren